Table 1.
General characteristics of study patients
| Parameters | Radiation sensitivity, n (%) | χ2 | P-value | |
|---|---|---|---|---|
| Radiation-resistant group | Radiation-sensitive group | |||
| Age (years) | 0.001 | 0.971 | ||
| <45 | 7 (13.5) | 45 (86.5) | ||
| ≥45 | 9 (13.2) | 59 (86.8) | ||
| Gender | 1.254 | 0.263 | ||
| Female | 9 (10.3) | 43 (82.7) | ||
| Male | 7 (17.3) | 61 (89.7) | ||
| Radiotherapy dose | 0.371 | 0.543 | ||
| <73.27 | 9 (15.3) | 50 (84.7) | ||
| ≥73.27 | 7 (11.5) | 54 (88.5) | ||
| AJCC stage | 1.254 | 0.263 | ||
| III | 9 (17.3) | 43 (82.7) | ||
| IVa | 7 (10.3) | 61 (89.7) | ||
| Chemotherapy | 0.246 | 0.620 | ||
| Yes | 14 (12.8) | 95 (87.2) | ||
| No | 2 (18.2) | 9 (81.8) | ||
| Targeted therapy | 0.526 | 0.428 | ||
| Yes | 1 (7.1) | 13 (92.9) | ||
| No | 15 (14.2) | 91 (85.8) | ||
| Sensitization therapy | 0.420 | 0.517 | ||
| Yes | 10 (15.2) | 56 (84.8) | ||
| No | 6 (11.1) | 48 (88.9) | ||
| MAP2K6 | 5.817 | 0.016 | ||
| Low | 2 (4.2) | 46 (95.8) | ||
| High | 14 (19.4) | 58 (80.6) | ||
Abbreviation: AJCC, American Joint Committee on Cancer.